Xiaolin Ge
Impact in
-
- Cancer-related molecular mechanisms research
-
- Esophageal Cancer Research and Treatment
- Esophageal and GI Pathology
Papers in
- Surgery 24
- Esophageal Cancer Research and Treatment 24
- Esophageal and GI Pathology 6
-
- Lung Cancer Diagnosis and Treatment 5
- Gastric Cancer Management and Outcomes 4
- Metastasis and carcinoma case studies 2
- Co-authors
- Xinchen Sun (13 shared papers)Xiaoke Di (7 shared papers)Liping Xu (4 shared papers)Baixia Yang (4 shared papers)Hongcheng Zhu (5 shared papers)Xi Yang (4 shared papers)Lulu Xu (2 shared papers)Xi-Sheng Liu (2 shared papers)
- Journals
- Frontiers in Oncology (4 papers)BMC Cancer (3 papers)Medicine (2 papers)Cancer Management and Research (2 papers)Acta Oto-Laryngologica (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Xiaolin Ge
39 papers receiving 362 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 52
- Surgery 132
- Oncology 58
- Pulmonary and Respiratory Medicine 67
- Radiology, Nuclear Medicine and Imaging 31
Countries citing papers authored by Xiaolin Ge
This map shows the geographic impact of Xiaolin Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Ge more than expected).
Fields of papers citing papers by Xiaolin Ge
This network shows the impact of papers produced by Xiaolin Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Ge. The network helps show where Xiaolin Ge may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolin Ge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 36 | |
| 2 | 2021 | 27 | |
| 3 | 2019 | 25 | |
| 4 | 2023 | 23 | |
| 5 | 2018 | 21 | |
| 6 | 2014 | 20 | |
| 7 | 2016 | 17 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 12 | |
| 10 | 2021 | 12 | |
| 11 | 2018 | 12 | |
| 12 | 2017 | 12 | |
| 13 | 2021 | 10 | |
| 14 | 2016 | 10 | |
| 15 | 2018 | 10 | |
| 16 | Silencing of high mobility group A1 enhances gemcitabine chemosensitivity of lung adenocarcinoma cells. | 2011 | 9 |
| 17 | 2019 | 8 | |
| 18 | 2022 | 8 | |
| 19 | 2019 | 8 | |
| 20 | 2021 | 7 |
About Xiaolin Ge
Xiaolin Ge is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Cancer Research, having authored 42 papers that have together received 362 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (24 papers), Esophageal and GI Pathology (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Gastric Cancer Management and Outcomes (4 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer Research and Treatments (2 papers), RNA modifications and cancer (2 papers) and Metastasis and carcinoma case studies (2 papers). The work is most often cited by research in Cancer Research (52 citations), Surgery (132 citations), Oncology (58 citations), Pulmonary and Respiratory Medicine (67 citations) and Radiology, Nuclear Medicine and Imaging (31 citations). Xiaolin Ge has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Xinchen Sun, Xiaoke Di, Liping Xu, Baixia Yang, Hongcheng Zhu, Xi Yang, Lulu Xu, Xi-Sheng Liu, Liang Liang and Sheng Zhang. Their work appears in journals such as Frontiers in Oncology, BMC Cancer, Medicine, Cancer Management and Research and Acta Oto-Laryngologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.